Short answer
Perspective Therapeutics, Inc. (CATX) filed its Q2 2026 10-Q quarterly report on Aug 10, 2026 for the quarter ended Jun 30, 2026.
Q2 2026 key financials · XBRL
- Net income
- −$27M
- −24.7% YoY · −2.3% QoQ
- EPS (diluted)
- −$0.22
- +24.1% YoY · +12.0% QoQ
Source: XBRL data from the Perspective Therapeutics, Inc. (CATX) Q2 2026 10-Q on SEC EDGAR. USD.
Perspective Therapeutics, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Risk Factors section not provided; supplied text begins with Item 2 and contains no risk disclosures
- No newly added, updated, regulatory, operational, competitive, market, or financial risks identifiable from the provided text
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Perspective Therapeutics, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.